Korean J Endocr Surg.  2010 Mar;10(1):29-33. 10.16956/kjes.2010.10.1.29.

Is Hashimoto's Thyroiditis Associated with the Prognostic Factors of Papillary Thyroid Carcinoma?

• Lee MJ
• Lee BK
• Youn HJ
• Jung SH

• KMID: 2375730
• DOI: http://doi.org/10.16956/kjes.2010.10.1.29

Abstract

PURPOSE
In recent studies, the presence of lymphocytic infiltration in patients with papillary thyroid carcinoma (PTC) was reported to be associated with a favorable prognosis. The prognostic significance of Hashimoto's thyroiditis (HT) in patients with PTC remains unclear. The aim of our study was to determine the frequency and prognostic significance of HT in patients with PTC.
METHODS
From January 2005 to December 2007, 367 patients who underwent thyroid surgery for PTC were included in this study. They were divided into two groups: Group A (n=71; 19.4%) included the patients diagnosed as having PTC with HT and Group B (n=296; 80.6%) included the patients who had PTC without HT. The clinicopathologic features between Groups A and B were retrospectively reviewed via the medical records.
RESULTS
Lymph node metastasis was less frequent in Group A than that in Group B (25.5% versus 41.0%, respectively, P=0.033). However, both groups had similar clinicopathologic features in terms of age, gender, the tumor size, multifocality, extrathyroidal invasion, the TNM stage and the AMES and MACIS scores. Also, the operative method did not differ significantly between the two groups.
CONCLUSION
These results suggest that the presence of HT is not associated with the prognostic factors of PTC.

Keyword

Papillary thyroid carcinoma; Hashimoto's thyroiditis; Prognostic factor

MeSH Terms

Humans
Lymph Nodes
Medical Records
Methods
Neoplasm Metastasis
Prognosis
Retrospective Studies
Thyroid Gland*
Thyroid Neoplasms*
Thyroiditis*

Reference

1.Singer PA. Thyroiditis acute, subacute and chronic. Med Clini North Am. 1991. 75:61–77.

2.Dailey ME., Lindsay S., Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg. 1955. 70:291–7.

3.Pino R., Guerra CM., Marcos GM., Trinidad RG., Pardo RG., Gonzalez PA, et al. The incidence of thyroid carcinoma in Hashimoto's thyroiditis: our experience and literature review. An Otorrinolaringol Ibero Am. 1997. 31:223–30.

4.Pisanu A., Piu S., Cois A., Ucchedu A. Coexisting Hashimoto's thyroiditis with differentiated thyroid cancer and benign thyroid disease: indication for thyroidectomy. Chir Ital. 2003. 55:365–72.

5.Xu S., Wang P., Yu Z. Clinical research of Hashimoto's disease with thyroid carcinoma. Zhonghua Yi Zue Za Zhi. 2000. 80:278–9.

6.Loh KC., Greenspan FS., Dong F., Miller TR. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 1999. 84:458–63.

7.Shim YS., Lee YS., Lee GH., Lee BC Jung YW., Lee JW, et al. Clinical assessment and management of papillary thyroid carcinoma with coexistent Hashimoto's thyroiditis. Korean J Otolaryngol-Head Neck Surg. 2007. 50:537–41.

8.Del RP., Cataldo S., Sommaruga L., Concione L., Arcuri MF., Sianesi M. The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer? Minerva Endocrinol. 2008. 33:1–5.

9.Pelizzo MR., Boschin IM., Toniato A., Piotto A., Pagetta C., Gross MD, et al. Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients. Clin Nucl Med. 2007. 32:440–4.

10.Aozasa K. Hashimoto's thyroiditis as a risk factor of thyroid lympoma. Acta Patholoica Japonica. 1990. 40:459–68.

11.Donckier JE., Michel L., Bendden VR., Delos M., Havaux X. Increased expression of endothelin-1 and its mitogenic receptor ETA in human papillary thyroid carcinoma. Clin Endo-crinol. 2003. 59:354–60.

12.Donckier JE. Increased expression of endothelin-1 and its mitogen receptor ET(A) in thyroid papillary carcinoma in humans. Bull Mem Acad R Med Belg. 2004. 159:384–8.

13.Unger P., Ewart M., Wang BY., Gan L., Kohtz DS., Burstein DE. Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroditis: a pathologic link? Hum Pathol. 2003. 34:764–9.

14.Repplinger D., Bargren A., Zhang YW., Adler JT., Haymart M., Chen H. Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Res. 2008. 150:49–52.

15.Cho HT., Chon SE., Park SG., Park YK. A clinical study of the coexisting thyroid carcinoma in Hashimoto's thyroiditis. J Korean Surg Soc. 1997. 52:656–61.

16.Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993. 328:553–9.

17.Yang J., Schnadig V., Logrono R., Wasserman PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007. 111:306–15.

18.Hall TL., Layfield LJ., Phillppe A., Rosenthal DL. Source of diagnositic error in fine needle apiration of the thyroid. Cancer. 1989. 63:718–25.

19.Kurukahvecioglu O., Taneri F., Yuksel O., Aydin A., Tezel E., Onuk E. Total thyroidectomy for the treatment of Hashimoto's thyroiditis coexisting with papillary thyroid carcinoma. Advances in Therapy. 2007. 24:510–6.

20.Matsubayashi S., Kawai K., Matsumoto Y., Mukuta T., Morita T., Hirai K, et al. The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab. 1995. 80:3419–20.

21.Mazzaferri EL., Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001. 86:1447–63.

22.Noguchi S., Noguchi A., Murakami N. Papillary carcinoma of the thyroid. I. Developing pattern of metastasis. Cancer. 1970. 26:1053–60.

23.Shaha AR., Shaha JP., Loree TR. Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol. 1996. 3:534–8.

24.Cady B., Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988. 104:947–53.